Editorial
Fármacos antifactor de necrosis tumoral alfa en pacientes con artritis reumatoide refractaria a tratamientos convencionales
Anti-TNF alpha agents in patients with rheumatoid arthritis refractory to conventional therapies
Miguel A. González-Gay
, Mario Agudo
Autor para correspondencia
Servicio de Reumatología, Hospital Universitario Marqués de Valdecilla, Santander, España
Leído
8778
Vecesse ha leído el artículo
1547
Total PDF
7231
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 0 | 3 | 3 |
| 2025 11 | 0 | 23 | 23 |
| 2025 10 | 0 | 9 | 9 |
| 2025 9 | 0 | 1 | 1 |
| 2025 8 | 0 | 4 | 4 |
| 2025 7 | 0 | 3 | 3 |
| 2025 6 | 0 | 8 | 8 |
| 2025 5 | 0 | 4 | 4 |
| 2025 4 | 0 | 12 | 12 |
| 2025 3 | 0 | 15 | 15 |
| 2025 2 | 0 | 12 | 12 |
| 2025 1 | 0 | 21 | 21 |
| 2024 12 | 0 | 6 | 6 |
| 2024 11 | 0 | 2 | 2 |
| 2024 10 | 0 | 17 | 17 |
| 2024 9 | 0 | 9 | 9 |
| 2024 8 | 0 | 9 | 9 |
| 2024 7 | 0 | 6 | 6 |
| 2024 6 | 0 | 5 | 5 |
| 2024 5 | 0 | 11 | 11 |
| 2024 4 | 0 | 28 | 28 |
| 2024 3 | 0 | 26 | 26 |
| 2024 2 | 0 | 15 | 15 |
| 2024 1 | 0 | 17 | 17 |
| 2023 12 | 0 | 37 | 37 |
| 2023 11 | 0 | 46 | 46 |
| 2023 10 | 0 | 65 | 65 |
| 2023 9 | 0 | 28 | 28 |
| 2023 8 | 0 | 16 | 16 |
| 2023 7 | 0 | 35 | 35 |
| 2023 6 | 0 | 16 | 16 |
| 2023 5 | 0 | 6 | 6 |
| 2023 4 | 0 | 3 | 3 |
| 2023 3 | 1 | 0 | 1 |
| 2023 2 | 0 | 13 | 13 |
| 2022 1 | 0 | 8 | 8 |
| 2022 12 | 0 | 4 | 4 |
| 2022 11 | 0 | 19 | 19 |
| 2022 10 | 0 | 16 | 16 |
| 2022 9 | 0 | 9 | 9 |
| 2022 8 | 0 | 36 | 36 |
| 2022 7 | 0 | 7 | 7 |
| 2022 6 | 0 | 5 | 5 |
| 2022 5 | 0 | 14 | 14 |
| 2022 4 | 0 | 17 | 17 |
| 2022 3 | 0 | 14 | 14 |
| 2022 2 | 0 | 2 | 2 |
| 2021 1 | 0 | 1 | 1 |
| 2021 12 | 0 | 4 | 4 |
| 2021 11 | 0 | 8 | 8 |
| 2021 10 | 0 | 7 | 7 |
| 2021 8 | 0 | 2 | 2 |
| 2021 6 | 0 | 6 | 6 |
| 2021 5 | 0 | 10 | 10 |
| 2021 4 | 0 | 8 | 8 |
| 2021 3 | 0 | 11 | 11 |
| 2021 2 | 0 | 3 | 3 |
| 2020 1 | 0 | 2 | 2 |
| 2020 12 | 0 | 5 | 5 |
| 2020 11 | 0 | 4 | 4 |
| 2020 10 | 0 | 3 | 3 |
| 2020 9 | 0 | 13 | 13 |
| 2020 8 | 0 | 9 | 9 |
| 2020 7 | 0 | 10 | 10 |
| 2020 6 | 0 | 4 | 4 |
| 2020 5 | 0 | 8 | 8 |
| 2020 4 | 0 | 5 | 5 |
| 2020 3 | 0 | 12 | 12 |
| 2020 2 | 0 | 13 | 13 |
| 2020 1 | 0 | 17 | 17 |
| 2019 12 | 0 | 39 | 39 |
| 2019 11 | 0 | 6 | 6 |
| 2019 10 | 0 | 17 | 17 |
| 2019 9 | 0 | 9 | 9 |
| 2019 8 | 0 | 15 | 15 |
| 2019 7 | 0 | 10 | 10 |
| 2019 6 | 0 | 34 | 34 |
| 2019 5 | 0 | 129 | 129 |
| 2019 4 | 0 | 13 | 13 |
| 2019 3 | 0 | 14 | 14 |
| 2019 2 | 0 | 6 | 6 |
| 2019 1 | 1 | 5 | 6 |
| 2018 12 | 0 | 8 | 8 |
| 2018 11 | 0 | 15 | 15 |
| 2018 10 | 0 | 11 | 11 |
| 2017 11 | 1 | 0 | 1 |
| 2017 10 | 133 | 1 | 134 |
| 2017 9 | 162 | 9 | 171 |
| 2017 8 | 138 | 4 | 142 |
| 2017 7 | 190 | 4 | 194 |
| 2017 6 | 177 | 3 | 180 |
| 2017 5 | 177 | 4 | 181 |
| 2017 4 | 136 | 5 | 141 |
| 2017 3 | 230 | 35 | 265 |
| 2017 2 | 519 | 0 | 519 |
| 2016 1 | 204 | 2 | 206 |
| 2016 12 | 152 | 6 | 158 |
| 2016 11 | 221 | 3 | 224 |
| 2016 10 | 203 | 14 | 217 |
| 2016 9 | 208 | 12 | 220 |
| 2016 8 | 146 | 10 | 156 |
| 2016 7 | 128 | 10 | 138 |
| 2016 6 | 157 | 7 | 164 |
| 2016 5 | 131 | 7 | 138 |
| 2016 4 | 157 | 9 | 166 |
| 2016 3 | 129 | 10 | 139 |
| 2016 2 | 149 | 15 | 164 |
| 2015 1 | 124 | 11 | 135 |
| 2015 12 | 128 | 14 | 142 |
| 2015 11 | 214 | 12 | 226 |
| 2015 10 | 193 | 10 | 203 |
| 2015 9 | 142 | 11 | 153 |
| 2015 8 | 107 | 10 | 117 |
| 2015 7 | 124 | 11 | 135 |
| 2015 6 | 90 | 4 | 94 |
| 2015 5 | 115 | 8 | 123 |
| 2015 4 | 102 | 14 | 116 |
| 2015 3 | 96 | 10 | 106 |
| 2015 2 | 99 | 6 | 105 |
| 2015 1 | 74 | 8 | 82 |
| 2014 12 | 86 | 8 | 94 |
| 2014 11 | 98 | 1 | 99 |
| 2014 10 | 87 | 4 | 91 |
| 2014 9 | 78 | 6 | 84 |
| 2014 8 | 89 | 2 | 91 |
| 2014 7 | 99 | 4 | 103 |
| 2014 6 | 83 | 2 | 85 |
| 2014 5 | 61 | 4 | 65 |
| 2014 4 | 53 | 1 | 54 |
| 2014 3 | 67 | 5 | 72 |
| 2014 2 | 38 | 2 | 40 |
| 2014 1 | 37 | 4 | 41 |
| 2013 12 | 43 | 3 | 46 |
| 2013 11 | 42 | 7 | 49 |
| 2013 10 | 32 | 1 | 33 |
| 2013 9 | 25 | 7 | 32 |
| 2013 8 | 44 | 4 | 48 |
| 2013 7 | 34 | 5 | 39 |
| 2013 5 | 1 | 0 | 1 |
| 2010 5 | 676 | 0 | 676 |
Mostrar todo
